Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10519241 Antibody constructs for EGFRVIII and CD3

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
August 1, 2016
Date of Patent
December 31, 2019
Patent Application Number
15225627
Patent Citations Received
‌
US Patent 11987633 Cross-species-specific single domain bispecific single chain antibody
0
‌
US Patent 11447567 Antibody constructs for FLT3 and CD3
‌
US Patent 11884720 Antibody constructs for MSLN and CD3
0
‌
US Patent 11938152 High-dose antioxidants in cancer treatment
0
‌
US Patent 10683351 Antibody constructs for DLL3 and CD3
‌
US Patent 10981998 Cross-species-specific single domain bispecific single chain antibody
‌
US Patent 11591396 Antibody constructs for DLL3 and CD3
‌
US Patent 11617767 Armed dual CAR-T compositions and methods for cancer immunotherapy
0
‌
US Patent 11434302 Bispecific T cell engaging antibody constructs
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10519241
Patent Primary Examiner
‌
Claire Kaufman

Find more entities like US Patent 10519241 Antibody constructs for EGFRVIII and CD3

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo